Crohn's and Colitis Foundation

Episode #69: Understanding the Financial Burden of IBD | Kevin Harlen & Laura Wingate | Crohn’s & Colitis Foundation

Podcast: Play in new window | Download | Embed

Kevin Harlen interviews Laura Wingate, chief education, support, and advocacy officer with the Crohn’s & Colitis Foundation about a recent survey which shows that more than 40 percent of patients with inflammatory bowel disease (IBD) have made significant financial trade-offs to afford their healthcare.

Crohn’s and Colitis Foundation Appoints Dr. Douglas Wolf to National Board of Trustees

Dr. Douglas Wolf, a United Digestive physician and Medical Director for the Center for Crohn’s Disease & Ulcerative Colitis, has joined the National Board of Trustees of the Crohn’s and Colitis Foundation, which focuses on IBD research and patient support.

Dr. Wolf has spent more than four decades dedicated to advancing the understanding and treatment of IBD through clinical practice, research, and patient advocacy. His extensive clinical research covers various aspects of IBD, including diagnostic testing, colonoscopy, capsule endoscopy, and therapy.

Episode #48: New Biosimilars Available to Treat IBD (what it means for your patients)

Podcast: Play in new window | Download | Embed

This summer, four new biosimilar drugs became available to U.S. patients and several more are expected to hit the market soon.

Dr. Michael Weinstein interviews Laura D. Wingate, executive vice president, education, support, & advocacy for the Crohn’s & Colitis Foundation about the positive and negative implications of this development for patients.

Episode #21: Educating and Advocating on Behalf of IBD Patients and Caregivers (diversity and inclusion are mission critical)

Podcast: Play in new window | Download | Embed

This week, Kevin Harlen talks with Michael Osso, president and CEO of the Crohn’s & Colitis Foundation about its mission to cure inflammatory bowel disease (IBD) and to improve the quality of life for children and adults affected by these diseases.